A problem for biopharmaceutical companies comes as degraded proteins lead to ineffective and possibly dangerous medicines for their clients. Drug companies work on formulation development to protect ...

Spray-dried protein microparticles without MoNi surfactant form paste-like materials (left), whereas those spray dried with MoNi surfactant form injectable suspensions that flow like liquids (right).

Formulation development is one of the critical steps in advancing a protein or a peptide as a therapeutic product. The challenge is to maintain the integrity of the complex and the often highly ...

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...

Protein therapeutics like insulin and GLP-1 inhibitors have a problem. They tend to aggregate when heated or shaken, robbing them of their potency. Researchers have now developed a ...

With GLP-1 use rising across the country, major brands are boosting protein, cutting sugar, and reworking formulations and ...

European Space Agency (ESA) astronaut Thomas Pesquet removes the Protein Crystallization Facility hardware from an incubator ...

For more than two decades, the International Space Station has provided a platform for growing and studying protein crystals. In the early days of microgravity research, scientists discovered that ...